NREF同业对比
NREF 与SIC 6798 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NREF本股 | $301M#7 | 6.8x#3 | 2.2x#13 | — | — | 242.4%#2 | — | 91.6%#3 | 19.4%#3 | — | — | 11.7%#6 |
| LAND | $405M#1 | — | 0.6x#7 | 33.3x#11 | — | 1.8%#8 | 93.5%#2 | 2.0%#7 | 1.0%#8 | — | — | 5.1%#10 |
| TPTS | $373M#2 | — | 2.9x#14 | 10.5x#10 | -28.7%#9 | 25.1%#7 | -3.7%#9 | -22.0%#15 | -0.6%#10 | — | — | 3.1%#11 |
| TCI | $346M#3 | 42.0x#8 | 0.4x#3 | 7.1x#9 | 4.2%#3 | 135.5%#3 | -12.9%#11 | 1.6%#8 | -0.6%#11 | — | — | — |
| LFT | $342M#4 | — | 1.7x#12 | — | — | -112.1%#13 | — | -1.3%#11 | — | — | — | 5.4%#9 |
| AIV | $324M#5 | 0.6x#1 | 0.9x#8 | 2.3x#2 | 0.6%#6 | 626.2%#1 | 85.0%#4 | 151.2%#1 | 19.5%#2 | — | — | 128.4%#1 |
| PINE | $317M#6 | 85.7x#9 | 0.9x#10 | 5.2x#6 | 15.9%#2 | -228.6%#15 | 21.7%#6 | -0.8%#10 | 1.6%#7 | — | — | 5.6%#8 |
| NXDT | $285M#8 | — | 0.4x#4 | 3.3x#4 | 3.3%#4 | -124.6%#14 | -1.6%#8 | -18.9%#14 | — | — | — | 2.1%#12 |
| REFI | $283M#9 | 8.1x#4 | 0.9x#9 | 5.8x#8 | — | -2.8%#9 | 85.5%#3 | 11.9%#4 | 7.5%#6 | — | — | 15.5%#4 |
| BRT | $262M#10 | — | 1.6x#11 | 2.7x#3 | 1.5%#5 | -21.4%#12 | -12.9%#10 | -7.4%#12 | -1.6%#12 | — | -8.1%#1 | 7.2%#7 |
| RC | $261M#11 | — | 0.2x#1 | — | — | 48.6%#6 | — | -17.8%#13 | 17.7%#4 | — | — | 43.4%#2 |
| ACRE | $241M#12 | 3.2x#2 | 0.5x#5 | 4.4x#5 | -21.3%#8 | 97.4%#4 | -1.1%#7 | -0.2%#9 | -0.0%#9 | — | — | 16.2%#3 |
| MITT | $201M#13 | 8.4x#6 | 0.4x#2 | — | — | -12.7%#10 | — | 8.9%#5 | 37.0%#1 | — | — | 12.2%#5 |
| STRW | $195M#14 | 21.5x#7 | 23.6x#15 | 1.3x#1 | 32.4%#1 | 85.0%#5 | 54.4%#5 | 91.8%#2 | 10.9%#5 | — | — | — |
| SEVN | $166M#15 | 8.3x#5 | 0.5x#6 | 5.7x#7 | -16.7%#7 | -13.4%#11 | 166.6%#1 | 4.7%#6 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-17。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议